(GSEU) Goldman Sachs ActiveBeta - Ratings and Ratios
Equity, Securities, Stocks
Description: GSEU Goldman Sachs ActiveBeta
The Goldman Sachs ActiveBeta Europe Equity ETF (GSEU) is designed to provide investors with exposure to European developed markets equities, tracking an index that captures the performance of this specific segment. By investing at least 80% of its assets in securities included in its underlying index, the fund aims to replicate the indexs returns, thereby offering a diversified portfolio of European equities.
To achieve its investment objective, GSEU may also invest in depositary receipts representing securities in its underlying index and underlying stocks related to these depositary receipts. This approach enables the fund to gain comprehensive exposure to the European equity market, leveraging the liquidity and diversification benefits associated with ETFs. For the most current information and detailed insights into the funds holdings and performance, investors can visit the official Goldman Sachs Asset Management website at http://www.gsamfunds.com.
Analyzing the current technical data, GSEUs last price is $41.65, indicating a positive trend as it is at its 52-week high. The SMA20, SMA50, and SMA200 are $40.50, $39.25, and $37.25, respectively, suggesting a bullish trend as the short-term moving averages are above the long-term averages. The Average True Range (ATR) of 0.69, or 1.66%, indicates moderate volatility. Given these technical indicators, a potential forecast could involve a continued upward trend, with potential resistance levels to watch in the near term.
From a fundamental perspective, the Assets Under Management (AUM) of $100.28 million USD signify a reasonable scale for the ETF, potentially offering liquidity to investors. Combining this with the technical analysis, a forecast for GSEU could involve reaching new 52-week highs in the near future, potentially testing resistance around $42.50-$43.00, based on the current upward momentum and assuming the European equity markets continue to perform positively. Investors should monitor the funds tracking efficiency, fees, and the overall European market conditions to adjust their strategies accordingly.
Additional Sources for GSEU ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
GSEU ETF Overview
Market Cap in USD | 107m |
Category | Europe Stock |
TER | 0.25% |
IPO / Inception | 2016-03-02 |
GSEU ETF Ratings
Growth Rating | 62.1 |
Fundamental | - |
Dividend Rating | 42.7 |
Rel. Strength | 2.28 |
Analysts | - |
Fair Price Momentum | 40.52 USD |
Fair Price DCF | - |
GSEU Dividends
Dividend Yield 12m | 0.56% |
Yield on Cost 5y | 0.91% |
Annual Growth 5y | 13.43% |
Payout Consistency | 89.4% |
Payout Ratio | % |
GSEU Growth Ratios
Growth Correlation 3m | 91.9% |
Growth Correlation 12m | 60.9% |
Growth Correlation 5y | 69.5% |
CAGR 5y | 11.66% |
CAGR/Max DD 5y | 0.34 |
Sharpe Ratio 12m | 1.29 |
Alpha | 7.11 |
Beta | 0.677 |
Volatility | 12.63% |
Current Volume | 8.7k |
Average Volume 20d | 21.2k |
As of July 04, 2025, the stock is trading at USD 42.35 with a total of 8,706 shares traded.
Over the past week, the price has changed by +1.29%, over one month by +2.16%, over three months by +12.98% and over the past year by +18.49%.
Yes. Based on ValueRay's Analyses, Goldman Sachs ActiveBeta (NYSE ARCA:GSEU) is currently (July 2025) a good stock to buy. It has a ValueRay Growth Rating of 62.07 and therefor a clear technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of GSEU is around 40.52 USD . This means that GSEU is currently overvalued and has a potential downside of -4.32%.
Goldman Sachs ActiveBeta has no consensus analysts rating.
According to our own proprietary Forecast Model, GSEU Goldman Sachs ActiveBeta will be worth about 46.3 in July 2026. The stock is currently trading at 42.35. This means that the stock has a potential upside of +9.26%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 46.3 | 9.3% |